Completed NA INTERVENTIONAL 2-arm NCT01614262

Examining The Role of CGM in T2DM

Examining the Role of Continuous Glucose Monitoring (CGM) in Non-Insulin Treated Type 2 Diabetes

Sponsor: Atlanta Diabetes Associates

Conditions DIABETES MELLITUS, NONINSULIN-DEPENDENT, 2 (Disorder)

Interventions Continuous Glucose Monitoring with treatment algorithm

Updated 7 times since 2017 Last updated: Apr 17, 2017 Started: Jun 30, 2012 Primary completion: Sep 30, 2014 Completion: Sep 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on DIABETES MELLITUS, NONINSULIN-DEPENDENT, 2 (Disorder), this trial is completed. The trial is conducted by Atlanta Diabetes Associates and has accumulated 7 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
May 2017 — Jun 2018 [monthly]

Completed NA

Status: Active Not Recruiting → Completed

▶ Show 2 earlier versions

Feb 2017 — May 2017 [monthly]

Active Not Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting NA

First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Atlanta Diabetes Associates
Medtronic
UNC Coordinating Center
University of North Carolina, Chapel Hill

Data source: University of North Carolina, Chapel Hill

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Atlanta, United States
• Chapel Hill, United States